• BMX-IN-1: Advanced BMX Kinase Inhibitor Workflows in Cell Mo

  2026-06-17

  BMX-IN-1 enables precise, irreversible BMX kinase inhibition for dissecting Tec family signaling in cancer and infectious disease models. Its performance at low nanomolar concentrations and covalent mechanism empowers researchers to probe cell cycle arrest, apoptosis, and host-pathogen interactions with high selectivity.

• Magnetic Nano-Antibody Enables In Vivo CAR-T-Mimicry for Sol

  2026-06-16

  This study introduces a magnetic bispecific nano-antibody (M-BiNanoAb) for in vivo generation and guidance of CAR-T-mimicking cells, overcoming key barriers in solid tumor immunotherapy. By combining anti-CD3 and anti-PDL1 functionalities with magnetic navigation, the approach enhances T cell infiltration and tumor cytotoxicity, offering a promising alternative to ex vivo CAR-T engineering.

• Methotrexate as a Folate Antagonist: Permeability, Mechanism

  2026-06-16

  Explore the multifaceted role of Methotrexate as a folate antagonist, with an in-depth focus on membrane permeability, apoptosis induction, and advanced assay optimization. This article integrates new biomimetic chromatography insights to guide experimental decisions in immunology and inflammation research.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor Ev

  2026-06-15

  Wang et al. (2018) provide mechanistic insight into how genotype III grass carp reovirus (GCRV104) enters host cells, demonstrating that clathrin-mediated, dynamin- and pH-dependent endocytosis is required. Their inhibitor profiling, including actin cytoskeleton disruption with Latrunculin B, shows that actin polymerization is dispensable for viral entry, refining antiviral research strategies.

• Tamsulosin Reduces Postoperative Urinary Retention: Meta-Ana

  2026-06-15

  A recent systematic review and meta-analysis specifically evaluated Tamsulosin, a selective α1A-adrenergic receptor antagonist, for the prevention of postoperative urinary retention (POUR). The study demonstrates that perioperative administration of Tamsulosin significantly reduces POUR risk and increases urinary flow rates, supporting its consideration in surgical care protocols.

• Epalrestat: Bridging Polyol Pathway Inhibition & Neuroprotec

  2026-06-14

  This article explores the translational frontier of Epalrestat, a potent aldose reductase inhibitor, highlighting its dual role in diabetic complication and neurodegenerative research. Integrating mechanistic insights on KEAP1/Nrf2 pathway activation with practical guidance, it addresses experimental design, competitive benchmarks, and strategic directions for researchers aiming to unlock new therapeutic avenues in oxidative stress and Parkinson's disease models.

• Arachidonic Acid Supplementation Accelerates Humoral Immunit

  2026-06-13

  The referenced study demonstrates that dietary arachidonic acid (ARA) supplementation significantly enhances the speed and magnitude of rabies vaccine-induced humoral immunity in both mice and humans. This work reveals novel mechanisms by which polyunsaturated fatty acids modulate germinal center B cell activation, with implications for dietary strategies and vaccine adjuvant design.

• Hoechst 33258: Precision Bis-Benzimide DNA Stain for Tumor R

  2026-06-12

  Hoechst 33258, a bis-benzimide DNA stain, delivers exceptional sensitivity and versatility for DNA visualization in live and fixed cells, making it invaluable for advanced tumor biology and pH microenvironment studies. This guide details optimized protocols, troubleshooting strategies, and innovative applications that leverage its unique minor groove binding for reliable results in even the most challenging experimental contexts.

• PERK Loss Sensitizes Colorectal Cancer to Ferroptosis via SL

  2026-06-12

  This study reveals that loss of PERK function in colorectal cancer downregulates SLC7A11, sensitizing tumor cells to ferroptosis. The findings identify the PERK-ATF4-SLC7A11 axis as a regulatory mechanism of ferroptotic cell death, offering new angles for therapeutic intervention in apoptosis-resistant tumors.

• MDM1 Overexpression Boosts p53-Mediated Apoptosis in CRC The

  2026-06-11

  This study demonstrates that MDM1 overexpression enhances p53 expression and cancer cell apoptosis, increasing the therapeutic sensitivity of colorectal cancer (CRC) cells to chemoradiotherapy. The results highlight the potential of MDM1 as a predictive marker for treatment response and suggest mechanistic pathways that may be targeted in future research.

• BMX-IN-1: Precision BMX Kinase Inhibition for Cancer & Infec

  2026-06-11

  BMX-IN-1 enables targeted, irreversible BMX kinase inhibition, delivering robust results in cancer, immunity, and host-pathogen studies. This guide details actionable protocols, real-world troubleshooting, and novel insights from host-directed TB research, setting BMX-IN-1 apart for advanced experimental workflows.

• Optimizing B-Cell Receptor Signaling Inhibition with PCI-327

  2026-06-10

  Ibrutinib (PCI-32765) enables precise, reproducible inhibition of BTK for dissecting B-cell activation and survival pathways in chronic lymphocytic leukemia and autoimmune disease research. This guide translates advanced workflows, experimental insights, and troubleshooting strategies for maximizing its impact in bench applications.

• Necrostatin 2 (Nec-2): Protocols & Innovations in Necroptosi

  2026-06-10

  Necrostatin 2 (Nec-2) stands out as a gold-standard RIPK2 inhibitor for dissecting necroptosis and programmed necrotic cell death, with proven value in translational models like ischemic stroke. This article provides practical workflows, troubleshooting guidance, and insight into how Nec-2 integrates with emerging membrane biology for advanced research applications.

• Y-27632 ROCK Inhibitor: Advancing Organoid and Cytoskeletal

  2026-06-09

  Y-27632, a selective ROCK inhibitor from APExBIO, empowers researchers to reliably modulate cytoskeletal dynamics and streamline organoid culture workflows. Its proven efficacy in cell stress fiber disruption and robust performance in patient-derived models make it an indispensable tool for modern cancer biology and translational research.

• Erastin: Precision Ferroptosis Inducer for Cancer Biology

  2026-06-09

  Erastin is a rigorously validated ferroptosis inducer that selectively triggers iron-dependent, oxidative cell death in RAS or BRAF mutant tumor cells. Its mechanism involves inhibition of system Xc⁻ and VDAC modulation, leading to glutathione depletion and ROS accumulation. This product is central to ferroptosis research and advanced cancer biology workflows.

12973 records 1/865 page Next 12345 下5页 Last page